See also this year's filing and all EDGAR filings for this company.
PDF Report 0001094038_2012_Marker_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001094038, Marker Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 307,921 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 32,291 |
| 4 | LiabilitiesCurrent | 3,800,572 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 3,316,189 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 46,480 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 340,212 |
| 1 | Liabilities | 3,800,572 |
| 2 | Expenses | 3,316,189 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -3,460,360 |
| 5 | NetIncome | -3,269,709 |
| 6 | ComprehensiveNetIncome | -3,269,709 |
| 7 | BaseVar | 3,751,726 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -5.22 |
| 9 | EconomicCapitalRatio | 0.159 |
Edgar->Model Mapping
Feature Distribution
